May 10th 2024
A recently published study investigated the impacts of a branded probiotic from ADM, and a heat-treated postbiotic version of the same strain on diarrhea-predominant irritable bowel syndrome.
FrieslandCampina gains TGA approval for Biotis prebiotic galactooligosaccharides in Australia
May 16th 2023Australia’s Therapeutic Goods Administration (TGA) has added galactooligosaccharides (GOS) to its Permissible Ingredients Determination for listed complementary medicines in Australia, announced GOS ingredient supplier FrieslandCampina Ingredients.
Gnosis by Lesaffre announced expansion of LifeinU L. Rhamnosus GG range
April 27th 2023Gnosis by Lesaffre has launched a new product in its probiotic range called LifeinU L. rhamnosus GG 350, which is a new quality specification of its existing reference probiotic bacteria, LifeinU L. rhamnosus GG.